Amphstar Pharmaceuticals, Inc. (AMPH) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Amphstar Pharmaceuticals, Inc. · Health Care · ref. ETF XLV · 50 calls · price $21.88
What the company does: Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise.
📈 Amphstar Pharmaceuticals, Inc. (AMPH) stock price
$21.88-27.7% over range
Aug 28, 25low $16.87 · high $30.81Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 6 analysts
📊 JPI status : Amphstar Pharmaceuticals, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 AMPH price target & analyst consensus — price $21.88
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$23+5.1%
Median target · of 6 targets$20-8.6%
Lowest target · 3 firms of 6$20-8.6%
Current price$21.88
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
350%
$22 ↔ $30
Below
350%
$20
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold583%
Sell117%
Strong Sell00%
Go deeper on the analysts
🎯 AMPH price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on AMPH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in AMPH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Amphstar Pharmaceuticals, Inc.? The JPI assistant answers using our backtest data.
✅ Historical analyst reliability on AMPH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 67% | +28.8% | 6 |
| Piper Sandler ↗ | 67% | +10.4% | 6 |
| Raymond James ↗ | 50% | +31.5% | 2 |
| Needham ↗ | 50% | +24.5% | 2 |
| Wells Fargo ↗ | 33% | -13.1% | 3 |
📊 What $1,000 invested in Amphstar Pharmaceuticals, Inc. would be worth › open the full page
In short — $1,000 invested in Amphstar Pharmaceuticals, Inc. 10 years ago would be worth $1,322 today, i.e. +3%/yr on average. Best year: 2023 (+121%), worst: 2024 (-40%). Price performance, excluding dividends.
If I'd invested $1,000 in Amphstar Pharmaceuticals, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $506 | -49% |
| 3 years ago | $671 | -33% |
| 5 years ago | $935 | -6% |
Return by year (Amphstar Pharmaceuticals, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -30% | $702 (-30%) |
| 2025 | -28% | $506 (-49%) |
| 2024 | -40% | $304 (-70%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Amphstar Pharmaceuticals, Inc.
Loading news…
📋 All analyst calls on AMPH
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $21.74 — gap to target +6%
Today : $21.88 — gap to target +5%
🎯 on AMPH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
Piper Sandler ↗
Aug 7, 26
■ Neutral neutral · not a buy · 🎯$20
Price at call : $20.31 — gap to target -2%
Today : $21.88 — gap to target -9%
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Wells Fargo ↗
Aug 7, 26
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $20.31 — gap to target -2%
Today : $21.88 — gap to target -9%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
B of A Securities ↗
Jun 29, 26
▼ Underperform · 🎯$20
Price at call : $20.71 — upside -3%
Today : $21.88 — upside -9%
🎯 on AMPH : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.12 — gap to target +10%
Today : $21.88 — gap to target -9%
🎯 on AMPH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
Wells Fargo ↗
May 14, 26
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $17.3 — gap to target +10%
Today : $21.88 — gap to target -13%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Piper Sandler ↗
May 11, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $17.5 — gap to target +20%
Today : $21.88 — gap to target -4%
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
See the other 42 calls, newest to oldest
■ Hold neutral · not a buy · 🎯$22
Price at call : $20.99 — gap to target +5%
Today : $21.88 — gap to target +1%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Apr 21, 27
matures : Apr 21, 27
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $20.87 — gap to target +10%
Today : $21.88 — gap to target +5%
🎯 on AMPH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Wells Fargo ↗
Feb 27, 26
▲ Overweight · 🎯$30
Price at call : $21.01 — upside +43%
Today : $21.88 — upside +37%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
▲ Buy · 🎯$30
Price at call : $20.23 — upside +48%
Today : $21.88 — upside +37%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $25.71 — gap to target +17%
Today : $21.88 — gap to target +37%
🎯 on AMPH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Buy · 🎯$34
Price at call : $24.03 — upside +41%
Today : $21.88 — upside +55%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$36
Price at call : $24.52 — upside +47%
Today : $21.88 — upside +65%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
B of A Securities ↗
Aug 26, 25
■ Neutral neutral · not a buy · 🎯$32
Price at call : $30.49 — gap to target +5%
Today : $21.88 — gap to target +46%
🎯 on AMPH : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Aug 26, 26
matures : Aug 26, 26
▲ Buy · 🎯$36
Price at call : $30.35 — upside +19%
Today : $21.88 — upside +65%
Expected +19% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
-34.2%
stock -34% · XLV +28%
matured Aug 12, 26
Piper Sandler ↗
Aug 8, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $23.81 — gap to target +5%
Today : $21.88 — gap to target +14%
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $24.34 — gap to target +23%
Today : $21.88 — gap to target +37%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 12, 26
matures : May 12, 26
Wells Fargo ↗
May 8, 25
▲ Overweight · 🎯$35
Price at call : $24.65 — upside +42%
Today : $21.88 — upside +60%
Expected +42% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-22.9%
stock -23% · XLV +7%
matured May 8, 26
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
Piper Sandler ↗
Mar 21, 25
■ Neutral neutral · not a buy · 🎯$32
Price at call : $28.46 — gap to target +12%
Today : $21.88 — gap to target +46%
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Mar 21, 26
matures : Mar 21, 26
Piper Sandler ↗
Feb 4, 25
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.19 — gap to target +8%
Today : $21.88 — gap to target +65%
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Feb 4, 26
matures : Feb 4, 26
Wells Fargo ↗
Nov 22, 24
▲ Overweight · 🎯$55
Price at call : $45.46 — upside +21%
Today : $21.88 — upside +151%
Expected +21% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-41.3%
stock -41% · XLV +8%
matured Nov 22, 25
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
Piper Sandler ↗
Aug 8, 24
▲ Overweight · 🎯$66
Price at call : $44.06 — upside +50%
Today : $21.88 — upside +202%
Expected +50% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-46.0%
stock -46% · XLV -13%
matured Aug 8, 25
Piper Sandler ↗
Jun 27, 24
▲ Overweight · 🎯$71
Price at call : $40 — upside +78%
Today : $21.88 — upside +224%
Expected +78% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-42.6%
stock -43% · XLV -8%
matured Jun 27, 25
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 22, 25
matures : May 22, 25
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 9, 25
matures : May 9, 25
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Apr 10, 25
matures : Apr 10, 25
▲ Overweight · 🎯$60
Price at call : $47.33 — upside +27%
Today : $21.88 — upside +174%
Expected +27% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 49.3% · +6.9% (146 calls)
-40.7%
stock -41% · XLV +3%
matured Mar 5, 25
B of A Securities ↗
Nov 17, 23
■ Neutral neutral · not a buy · 🎯$63
Price at call : $55.85 — gap to target +13%
Today : $21.88 — gap to target +188%
🎯 on AMPH : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Nov 16, 24
matures : Nov 16, 24
Wells Fargo ↗
May 17, 23
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $42.97 — gap to target +2%
Today : $21.88 — gap to target +101%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 16, 24
matures : May 16, 24
Piper Sandler ↗
Oct 25, 22
▲ Overweight · 🎯$40
Price at call : $29.64 — upside +35%
Today : $21.88 — upside +83%
Expected +35% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+52.0%
stock +52% · XLV -3%
matured Oct 25, 23
Capital One
Jul 29, 22
▲ Overweight · 🎯$44
Price at call : $36.99 — upside +19%
Today : $21.88 — upside +101%
Expected +19% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on AMPH : 100% (1 call matured) · 📊 unranked overall
+64.1%
stock +64% · XLV +2%
matured Jul 29, 23
Wells Fargo ↗
Mar 15, 22
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $34.74 — gap to target -8%
Today : $21.88 — gap to target +46%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Mar 15, 23
matures : Mar 15, 23
Piper Sandler ↗
Mar 11, 22
▲ Overweight · 🎯$35
Price at call : $34.3 — upside +2%
Today : $21.88 — upside +60%
Expected +2% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+4.1%
stock +4% · XLV -3%
matured Mar 11, 23
Piper Sandler ↗
Jan 7, 22
▲ Overweight · 🎯$28
Price at call : $25.05 — upside +12%
Today : $21.88 — upside +28%
Expected +12% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 60% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+11.9%
stock +12% · XLV -1%
matured Jan 7, 23
Wells Fargo ↗
Mar 17, 21
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $17.99 — gap to target +11%
Today : $21.88 — gap to target -9%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Mar 17, 22
matures : Mar 17, 22
Wells Fargo ↗
Jan 8, 21
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $19.8 — gap to target +6%
Today : $21.88 — gap to target -4%
🎯 on AMPH : 0% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 8, 22
matures : Jan 8, 22
Northland Capital Markets ↗
Oct 5, 20
▲ Outperform
Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 15.4% · -20.8% (13 calls)
-6.5%
stock -6% · XLV +19%
matured Oct 5, 21
Northland Capital Markets ↗
Jul 9, 20
■ Market Perform neutral · not a buy · 🎯$23
Price at call : $20.34 — gap to target +13%
Today : $21.88 — gap to target +5%
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 15.4% · -20.8% (13 calls)
in progress (365j)
matures : Jul 9, 21
matures : Jul 9, 21
BMO Capital ↗
May 11, 20
■ Market Perform neutral · not a buy · 🎯$21
Price at call : $18.53 — gap to target +13%
Today : $21.88 — gap to target -4%
🎯 on AMPH : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : May 11, 21
matures : May 11, 21
■ Hold neutral · not a buy
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Mar 12, 20
matures : Mar 12, 20
BMO Capital ↗
Mar 13, 18
■ Market Perform neutral · not a buy · 🎯$19
Price at call : $20.35 — gap to target -7%
Today : $21.88 — gap to target -13%
🎯 on AMPH : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Mar 13, 19
matures : Mar 13, 19
BMO Capital ↗
Nov 10, 17
■ Market Perform neutral · not a buy · 🎯$17
Price at call : $18.55 — gap to target -8%
Today : $21.88 — gap to target -22%
🎯 on AMPH : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 10, 18
matures : Nov 10, 18
Raymond James ↗
Nov 9, 17
■ Market Perform neutral · not a buy
🎯 on AMPH : 100% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Nov 9, 18
matures : Nov 9, 18
Raymond James ↗
Mar 14, 17
▲ Outperform · 🎯$18
Price at call : $12.2 — upside +48%
Today : $21.88 — upside -18%
Expected +48% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on AMPH : 100% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
+65.9%
stock +66% · XLV +13%
matured Mar 14, 18
▲ Buy · 🎯$19
Price at call : $18.17 — upside +5%
Today : $21.88 — upside -13%
Expected +5% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on AMPH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
-16.0%
stock -16% · XLV +5%
matured Aug 10, 17
BMO Capital ↗
Jun 29, 16
■ Market Perform neutral · not a buy
🎯 on AMPH : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jun 29, 17
matures : Jun 29, 17
Frequently asked questions
Should I buy Amphstar Pharmaceuticals, Inc. stock?
This isn't buy advice. For Amphstar Pharmaceuticals, Inc., the analyst consensus is "Hold", with an average price target of $20.00 (-9% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (6 calls tracked on Amphstar Pharmaceuticals, Inc.). We show the numbers — you decide.
Is it too late to buy Amphstar Pharmaceuticals, Inc.? How high can it go?
The most bullish analyst target on Amphstar Pharmaceuticals, Inc. is $23.00 (+5% above today's price); the average is $20.00. That's the upside they see. Check how reliable those analysts have actually been on Amphstar Pharmaceuticals, Inc. on our site before trusting it.
Is Amphstar Pharmaceuticals, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 5 analysts have a real record on Amphstar Pharmaceuticals, Inc., the best hitting 67% over 6 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Amphstar Pharmaceuticals, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will AMPH stock recover (go back up)?
Should you invest in Amphstar Pharmaceuticals, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in AMPH (and why hesitate).
What has Amphstar Pharmaceuticals, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: AMPH performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX